TAK 21d (50 MG)
货号：
5209/50 基本售价：
11976.7 元 规格：
50 mg
产品信息
概述| 货号 | 5209/50 |
| 别名 | 4-[4-(3,4-Difluorophenyl)-2-pyrimidinyl]-N-3-pyridazinyl-1-piperazinecarboxamide |
性能| 供应商 | Tocris |
| 生物活性 | Potent FAAH inhibitor; (IC50 values are 0.28 and 0.72 nM, at rat and human FAAH respectively). Displays analgesic effects in vivo models of neuropathic and inflammatory pain. Brain penetrant. |
| 运输条件 | Blue Ice |
| 存放说明 | -20℃ |
| 纯度 | >98 % |
| 计算分子量 | 397.38 |
| 分子式 | C19H17F2N7 |
| 可溶性/溶解性 | Soluble to 10 mM in DMSO and to 20 mM in 1eq. HCl |
| 参考文献 | Konoet al (2014) Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors. Bioorg.Med.Chem. 22 1468. PMID: 24440478. |
